Results

Total Results: 376 records

Showing results for "renal".

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/gout_research-protocol.pdf
    November 03, 2014 - Hyperuricemia can be the result of either inadequate renal excretion of UA or, less commonly, UA overproduction … XOIs- allopurinol and febuxostat) to reduce sUA production; uricosurics probenecid, which prevents renal … differ according to patient baseline demographic characteristics and co-morbid conditions (including renal … • Patients with comorbidities, including hypertension, Type 2 diabetes, chronic kidney disease (renal … conducted by age group; particular comorbidities, such as patients with hypertension, type 2 DM, or renal
  2. effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1412.pdf
    December 01, 2014 - gout purportedly have insufficient excretion of uric acid, which could be due to genetic defects in renal … organic anion transporter involved in controlling the reabsorption of uric acid from the proximal renal … Monotherapy lesinurad resulted in more patients experiencing elevated serum creatinine levels and renal … However, better gout management could reduce hospitalizations and renal or cardiovascular complications … also provide cost offsets from treatment with lesinurad.18 One research expert noted concerns over renal
  3. effectivehealthcare.ahrq.gov/sites/default/files/pdf/erythropoiesis-stimulating-agents-utilization_research.pdf
    February 01, 2011 - Chronic renal disease affects more than 26 million Americans1 and is the cause of significant morbidity … a common complication, conveys signifi- cant risk for cardiovascular disease, faster progression of renal … failure, and decreased quality of life.3 In fact, most patients with chronic renal disease become … Early Anemia Treatment With Epoetin Beta [CREATE] 7 and Correction of Hemoglobin and Outcomes in Renal … Anemia in renal disease: diagnosis and management. Blood Rev 2010;24(1):39-47. 4. Nurko S.
  4. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-update_executive.pdf
    June 01, 2011 - Number 34 Effective Health Care 2 The renin system can be triggered by sympathetic stimulation, renal … used extensively for treatment of hypertension, heart failure, myocardial infarction, diabetes, and renal … There appears to be a small difference in change in diabetes control, renal function between ACEIs and … and switch rates). • Specific adverse events (including, but not limited to, weight gain, impaired renal … e Specific adverse events: These included, but were no limited to, weight gain, impaired renal function
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0320_06-17-2009.pdf
    January 01, 2009 - associated with these diseases (i.e., bone issues, elevated urine/serum protein, anemia, fatigue, or renal … What are the day-to-day biological variables, such as renal function, that affect the utility of FLC
  6. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_executive.pdf
    January 01, 2006 - Harms: hypertension, congestive heart failure (CHF), edema, and impaired renal function • All NSAIDs … Evidence regarding the comparative risk of renal dysfunction for celecoxib and rofecoxib is sparse. … event (peripheral edema, hypertension, or renal dysfunction) risk from 114 randomized trials of COX- … , although there was no difference for the prepecified, primary composite renal outcome of peripheral … edema, hypertension, renal dysfunction, or arrhythmia.
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/nephropathy-contrast-induced_disposition-comments.pdf
    January 07, 2016 - whether imaging was done on an urgent or elective basis, or other details such as the severity of renal … We know that CIN incidence varies dramatically based on baseline renal function, and the absence of … It is hypothesized that patients with normal or near-normal renal function "may have" a lower risk of … resulting from changes in creatinine production, tubular secretion, volue of distribution or extra-renal … Need for renal replacement therapy is addressed in all comparisons.
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/coronary-stents-outcomes_research.pdf
    January 01, 2010 - with DES plus a selected group of clinically important variables including: gender, age, diabetes, renal … As expected, mortality was higher in those with diabetes, renal failure, STEMI or CHF. … This effect was somewhat less pronounced in those with a prior history of CABG and renal failure, with … Similarly, the 30-month risk of MI was lower in all patient subgroups except those with renal failure … (Figure 4c) However, no benefit was observed in patients >75 years, or with diabetes, renal failure,
  9. TND-555-09-03-2013 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-555-09-03-2013.pdf
    January 01, 2013 - Completion Date: 02-13-2013 3 Control and Complications Trial (DCCT) (as measured by retinal, renal … A decrease in or prevention of diabetes-related complications (as measured by retinal, renal, cardiovascular
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/heart-failure-natriuretic-peptide_executive.pdf
    November 01, 2013 - The BNP concentration was inversely related to renal function. … Renal function: Two papers48,80 reported an inverse association between renal function and NT-proBNP … Renal function: One study assessed the effect of renal function on test performance.101 Patients were … function: One study101 examined the effect of renal function on the ability of NT-proBNP to identify … of both BNP and NT-proBNP, and to establish cutpoints in situations of reduced renal function
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_disposition-comments.pdf
    August 01, 2012 - I demanded from the owner of my medical center that I immediately be referred to a renal nutritionist … Renal Data System (USRDS) and the Behavioral Risk Factor Surveillance System (BRFSS). … Ruben Velez Renal Physicians Association In asymptomatic adults with or without recognized risk … A recent study by the Chronic Renal Insufficiency Cohort (CRIC) Study Group showed that treatment of … Diuretics, calciuria and secondary hyperparathyroidism in the Chronic Renal Insufficiency Cohort.
  12. Gout Executive (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout_executive.pdf
    March 01, 2016 - Both colchicine and NSAIDs require dose reduction in renal impairment. … Allopurinol treatment and its effect on renal function in gout: a controlled study. … Description and guidelines for prevention in patients with renal insufficiency. … Allopurinol-induced severe hypersensitivity with acute renal failure. … Allopurinol, erythema multiforme, and renal insufficiency. BMJ. 1996 Jan 20;312(7024):173-4.
  13. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer18-heart-disease-ace-inhibitor-arb-executive.pdf
    October 01, 2009 - presence and pattern of symptoms), dose of the ACE inhibitor or ARB used, comorbidities (diabetes, renal … Patients with renal dysfunction have at least as robust relative reductions in the risk of cardiovascular … Renal impairment Moderate • Combination of ACE inhibitor + ARB (ramipril + withdrawal telmisartan) has … more discontinuations due to renal impairment than ACE inhibitor (ramipril) alone. … Renal impairment Insufficient • No data are available evaluating ACE inhibitors or ARBs or hyperkalemia
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-stones-protocol.pdf
    September 24, 2024 - Patient-centered health outcomes: Incident symptomatic stones, urinary tract obstruction with acute renal … KQ 3, 3a, 3b, 4, 4a, 4b: Followup imaging when used for routine surveillance (CT scan, renal ultrasound … impairment, end-stage renal disease, urinary tract infection, stone-removal procedures/surgery, procedure … NICE Guideline - Renal and ureteric stones: assessment and management. … stone”[tw] OR “renal stones”[tw] OR “renal calcul*”[tw] OR  “staghorn calculi”[tw] OR “staghorn calculus
  15. effectivehealthcare.ahrq.gov/sites/default/files/pdf/pneumonia-antibiotic-treatment_research-protocol.pdf
    July 19, 2013 - empiric antibiotic-dosing regimens are based on data from noncritically ill patients (with or without renal … with new data derived from patients with HAP, including those who are critically ill with or without renal … Based on public comments, we have added renal dysfunction as a subgroup in KQ 3. … Subgroups:   • HAP, VAP, and HCAP • Immunocompromised • Age, sex, race, and ethnicity • Renal … Roberts DM, Roberts JA, Roberts MS, et al; RENAL Replacement Therapy Study Investigators.
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-stone-prevention_executive.pdf
    March 01, 2013 - Renal stone epidemiology in Rochester, Minnesota: an update. … Kairaitis L, Caring for Australians with Renal I. The CARI guidelines. … Becker G, Caring for Australians with Renal I. The CARI guidelines. Kidney stones: cystine stones. … Becker G, Caring for Australians with Renal I. The CARI guidelines. … Placebo versus allopurinol for renal calculi. Journal of Urology. 1977 Jun;117(6):690-2.
  17. effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-future_research.pdf
    March 01, 2012 - Advances in antihypertensive therapy have dramatically reduced cardiovascular, cerebrovascular, and renal … intake on ACEI/ARB/DRI effectiveness or harms . 3 The impact of ACEI/ARB/DRI on progression of renal … Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes … There appears to be a small difference in change in renal function between ACE inhibitors and ARBs ( … Renal effects of aliskiren compared with and in combination with irbesartan in patients with type 2
  18. effectivehealthcare.ahrq.gov/sites/default/files/pdf/plasma-cell-dyscrasias-sflc-assay_research-protocol.pdf
    May 02, 2011 - marrow plasma cells ≤10%  Absence of end-organ damage (bone lesions, anemia, hypercalcemia, or renal … urinary monoclonal protein  Evidence of end-organ damage (bone lesions, anemia, hypercalcemia, or renal … marrow plasma cells ≥10%  Absence of end-organ damage (bone lesions, anemia, hypercalcemia, or renal … end-organ damage, including skeletal destruction (lytic bone lesions), hypercalcemia, anemia, and renal … This ratio remains normal in polyclonal hypergammaglobulinemia or in renal insufficiency where free
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-update-2015_research-protocol.pdf
    January 01, 2015 - • The inclusion of the safety outcomes of impaired renal function, urinary tract infections, genital … side effects; and for comparisons including SGLT-2 inhibitors, urinary tract infections, impaired renal … side effects; and for comparisons including SGLT-2 inhibitors, urinary tract infections, impaired renal … one of the following comorbid conditions: • End-stage liver disease or cirrhosis • End-stage renal … include studies addressing the following safety outcomes for KQ3: § Liver injury^ § Impaired renal
  20. Santa_ECCS2012 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/santa_eccs2012.pdf
    February 01, 2013 - Plain-­‐language versions of selected topics • Longer “stories” about more complex topics: chronic renal … Cancer (American Society of Clinical Oncology): “Even in cancer, more may not be better.” • Chronic  renal … failure (American Society of Nephrology): “Even in chronic renal disease, more treatment may not be

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: